A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects
Clinical trial NCT01289509 · COMPLETED
Trial details
- NCT number
- NCT01289509
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-03-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.